Navigation Links
Regulus Provides Update on 'Road to the Clinic' Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
Date:5/14/2013

continue to focus our efforts on preparing for a successful transition to a clinical-stage company and remain on track to nominate our second microRNA candidate for clinical development by the end of the year.  Our recent progress is encouraging and we look forward to realizing the potential that our microRNA technology may have in transforming the field of drug discovery."

Neil W. Gibson , Ph.D., Chief Scientific Officer, added, "We believe that RG-101 is a novel, pan-genotypic agent that may play an important role in future HCV therapy. We are very encouraged by the pre-clinical data seen to date, which includes activity against some of the known mutations that lead to resistance to the current HCV therapies and a favorable potency and PK profile which supports a once-a-month dosing paradigm.  We believe that RG-101 may be useful in difficult-to-treat HCV patients in combination with existing and emerging therapies and we look forward to exploring its clinical utility."

Garry E. Menzel , Ph.D., Chief Operating Officer and Executive Vice President of Finance, said, "As we prepare for clinical activity with RG-101, Regulus continues to maintain a strong financial position with over $90 million in cash at quarter-end. We remain on track to achieve our stated goals of finishing 2013 with at least $60 million in cash, while maintaining a burn rate of approximately $30 million to $35 million."

Recent Highlight

  • Selected New Opportunity in Oncology.  Regulus also announced today that it has selected microRNA-221 (miR-221) as an attractive target for potential clinical evaluation in patients with hepatocellular carcinoma (HCC).  Regulus is currently conducting target validation activities and expects to report further progress on this opportunity in the second half of 2013.
  • First Quarter 2013 Financial Results & Highlights Regulus reported a net loss o
    '/>"/>

    SOURCE Regulus Therapeutics Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Regulus Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
    2. Regulus Appoints William H. Rastetter, Ph.D. to its Board of Directors
    3. Regulus to Present at Future Leaders in the Biotech Industry Conference
    4. Regulus to Present at Cowen and Company 33rd Annual Healthcare Conference
    5. Regulus Reports Fourth Quarter and Year-End 2012 Financial Results and Highlights
    6. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
    7. Regulus to Present at Two Upcoming Investor Conferences
    8. Regulus Appoints Mark G. Foletta to its Board of Directors
    9. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
    10. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
    11. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/6/2015)... 6, 2015 Moerae Matrix, a clinical ... that target inflammation and fibrosis, today announced the ... as Chief Medical Officer. Dr. ... and programs, which include a pipeline of therapies ... conditions.  Bill is an accomplished strategist and scientist ...
    (Date:7/6/2015)... DUBLIN and SOUTH SAN FRANCISCO, ... plc (NYSE: AGN ), a leading global pharmaceutical ... on developing novel treatments for dry eye disease, today ... which Allergan will acquire Oculeve in an all-cash transaction. ... Oculeve for a $125 million upfront payment and commercialization ...
    (Date:7/5/2015)... Nihon University is pleased to announce ... Collaboration "Medicine Definitely Jumps Up with 8K" will ... Tokyo, Japan . Many experts on ... present their achievements and future prospects on progress ... with 8K technology. (Documentation: http://prw.kyodonews.jp/prwfile/release/M000079/201507031722/_prw_OA1fl_Xy4Q5W4x.pdf ...
    Breaking Medicine Technology:Moerae Matrix, Inc. (Moerae) Appoints Bill Bradford, M.D., PhD, as Chief Medical Officer 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3
    ... CHENGDU, China , June 28 ... biopharmaceutical company that specializes,in patented biopharmaceutical, modernized traditional Chinese ... product portfolio at,the 45th 2010 National New Special Drugs ... 8th , till July 10th . Tianyin,s portfolio ...
    ... SAN DIEGO , June 28 ADVENTRX Pharmaceuticals, ... added to the Russell Microcap® Index on June 25, 2010 , ... , , ... available only to companies listed on a national exchange, is consistent with ...
    Cached Medicine Technology:Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing 2Tianyin Promotes its Flagship Product Portfolio at the 45th 2010 National New Special Drugs Trade Fair in July at Beijing 3ADVENTRX Added to Russell Microcap Index 2
    (Date:7/6/2015)... ... 2015 , ... Diabetes affects many of us and the Glycemic Load and ... the majority of which are Type 2. However, eight million do not know they ... have prediabetes (abnormally high blood sugar levels). Without reductions in blood sugar levels and ...
    (Date:7/6/2015)... ... ... The Path of Least Resistance: The Evolution of Capitalism and Politics in America ... the past 40 years. The book explores the evolution of the global economy and ... time capsule that chronicles the economic development of the United States — from its ...
    (Date:7/5/2015)... ... July 06, 2015 , ... City Sports, the Boston-based specialty ... co-produce two training clinics for first-time triathletes this summer with ethos, the owner and ... on Thursday, July 9, at 6:00 p.m. at the North End Greenway. The event ...
    (Date:7/5/2015)... , ... July 05, 2015 , ... ... products, announces the Weed Master, a landscaping invention that effectively removes weeds ... billion US dollars," says Scott Cooper, CEO and Creative Director of World Patent ...
    (Date:7/5/2015)... ... July 05, 2015 , ... Doctors at the Swedish Cancer ... combination may one day change the outlook for people with pleural mesothelioma. Surviving Mesothelioma ... , Researchers report that five mesothelioma patients treated with 25Gy of radiation over ...
    Breaking Medicine News(10 mins):Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2Health News:New Book Brings Reveals The Repercussions Associated With The Global Economy 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2
    ... birth registration in certain parts of India is not satisfactory. ... still go unregistered . ,Two out of every five ... government planning purposes, Plan India, a non-governmental organisation (NGO) said. ... compulsory under the Registration of Births & Deaths (RBD) Act, ...
    ... Some people are unwilling or unable to stop smoking, but ... they smoke each day . ,After studying healthcare ... few reports that assessed methods aimed at helping people reduce ... of cigarettes delivers clear health benefits. ,The main effort ...
    ... small risk of sudden death when seated, and not only when ... Archives of Disease in Childhood , a British journal. ... unexpected deaths that occurred among infants up to the age of ... ,Of 508 fully investigated deaths, 17, or 3.3 percent, occurred in ...
    ... of almost a thousand no-sex-till-marriage organizations. Take for example ... beautiful teen Jami Waite, has been an emblem of ... a single operation in Longview, Texas, to become an ... and its not weird, Waite declares. , Yet, for ...
    ... to oil the wheels of retail-based medical clinics. Accordingly, ... operation of these clinics . They vouch that the ... and businesses to expand basic medical services. ... by CVS Caremark Corp. to open a retail clinic, ...
    ... Changes to the UK licensing laws have trebled the number ... reveals research in Emergency Medicine Journal . ,The ... the clock, took effect in November 2005. ,The ... of binge drinking and associated crime and disorder, and boost ...
    Cached Medicine News:Health News:Millions of Births Still Go Unreported in India 2Health News:Reducing Smoking - Mixed Messages and Latest Findings 2Health News:Virginity Rules-Meant To Be Broken? 2Health News:Virginity Rules-Meant To Be Broken? 3Health News:Retail Health Clinics Start Shop 2Health News:UK Licensing Law Changes Have Trebled Overnight Alcohol Related Visits to Emergency Care 2
    ... The pharmaceutical subset of the ... 21 of the Code of ... and final rules published in ... updated regularly as released by ...
    ... measuring principle - Pupil Zone Imaging Method ... offers high accuracy and reliability in refraction ... measurement (3.3 mm) using a mire ring, ... 4 points, both of which offer reliable ...
    The combination of new measuring principle - Pupil Zone Imaging Method - and unique technology - SLD - offers high accuracy and reliability in refraction measurement....
    ... The ISI Free-Standing upper extremity table ... and in-office procedures. This table features ... and an extra-durable, hour-glass shaped Lexan ... stable -- this table is our ...
    Medicine Products: